Enteropathogenic Escherichia coli (EPEC) use a type 3 secretion system (T3SS) for injection of effectors into host cells and intestinal colonization. Here, we demonstrate that the multicargo chaperone CesT has two strictly conserved tyrosine phosphosites, Y152 and Y153 that regulate differential effector secretion in EPEC. Conservative substitution of both tyrosine residues to phenylalanine strongly attenuated EPEC type 3 effector injection into host cells, and limited Tir effector mediated intimate adherence during infection. EPEC expressing a CesT Y152F variant were deficient for NleA effector expression and exhibited significantly reduced translocation of NleA into host cells during infection. Other effectors were observed to be dependent on CesT Y152 for maximal translocation efficiency. Unexpectedly, EPEC expressing a CesT Y153F variant exhibited significantly enhanced effector translocation of many CesT-interacting effectors, further implicating phosphosites Y152 and Y153 in CesT functionality. A mouse infection model of intestinal disease using Citrobacter rodentium revealed that CesT tyrosine substitution variants displayed delayed colonization and were more rapidly cleared from the intestine. These data demonstrate genetically separable functions for tandem tyrosine phosphosites within CesT. Therefore, CesT via its C-terminal tyrosine phosphosites, has relevant roles beyond typical type III secretion chaperones that interact and stabilize effector proteins.
Introduction
Enterohaemorrhagic and Enteropathogenic Escherichia coli (EHEC and EPEC) are worldwide diarrheal pathogens that are associated with significant morbidity, and in extreme cases mortality (Kaper et al., 2004; Croxen and Finlay, 2010; Wong et al., 2011; Hazen et al., 2016) . The Type 3 Secretion System (T3SS) of these and other attaching and effacing (A/E) pathogens is a critical feature for host intestinal colonization (Marches et al., 2000; Tacket et al., 2000; Ritchie et al., 2003; Deng et al., 2004) . These bacteria use their respective T3SS to inject a variety of effector proteins directly into host cells thereby subverting host cell functions and enabling the bacteria to evade the host's innate immune responses (Pearson et al., 2016) . A hallmark of A/E pathogen gut infection is microcolony formation and intestinal lesions. Furthermore, strains that express Shiga Toxin (e.g., STEC/VTEC) during human disease can produce a kidney pathology termed hemolytic uremic syndrome (HUS), and in severe cases systemic neuropathology (Karmali et al., 1983; Pacheco and Sperandio, 2012) .
The coordinated regulation of T3SS expression and subsequent effector translocation are considered critical factors for EHEC/EPEC infection and disease progression (Mellies et al., 2007; Tree et al., 2009; Bustamante et al., 2011; Xu et al., 2012) . A genetic pathogenicity island, the locus of enterocyte effacement (LEE-PAI), encodes the structural protein components of the T3SS, along with regulators, chaperones and effectors (Pearson et al., 2016) . Additional pathogenicity islands found within the EHEC and EPEC chromosomes encode effectors that are secreted by the LEE encoded T3SS (Hayashi et al., 2001; Perna et al., 2001; Tobe et al., 2006; Iguchi et al., 2009) . Interestingly, a temporal hierarchy for translocon protein secretion (EspA, B and D) and effector secretion has been observed (Mills et al., 2008; Portaliou et al., 2017; Shaulov et al., 2017) , indicating that EPEC has a tiered mechanism to first coordinate translocon and subsequently effector injection into host cells. Low calcium sensing by EPEC has been implicated in transitioning from translocon to effector protein secretion (Shaulov et al., 2017) . The first secreted, or hierarchical effector, is the translocated intimin receptor (Tir) (Thomas et al., 2007; Ramu et al., 2013) , although the mechanism behind this hierarchy remains elusive. Once Tir is translocated and localized within the host cytoplasmic membrane, it acts as a high affinity surface exposed receptor for intimin which is embedded within the outer membrane of EHEC/EPEC (Kenny et al., 1997; Brady et al., 2011) . In concert with other host proteins, Tir further acts to subvert host cytoskeletal function. Notably, Tir has been shown to be essential for intestinal disease (Ritchie et al., 2003; Deng et al., 2004) , an observation consistent with the importance of Tir effector hierarchy. Several other effectors are involved in altering innate immune activity and signalling (EspF, NleA, NleB, NleC, NleD, NleE and NleH1/H2) while others have subversive effects on cellular pathways [Map, EspH, NleG, reviewed in [Wong et al., 2011; Pearson et al., 2016] ).
CesT is a 156 amino acid EPEC/EHEC multicargo Type 3 Secretion Chaperone (T3SC, class 1B) that forms homodimers within the bacterial cytoplasm (Luo et al., 2001; Thomas et al., 2012) . The CesT protein sequence (Genbank accession number CAS11488.1) is highly conserved (96%-100% identity) across all serotypes and strains within publicly accessible databases. Located within the LEE-PAI, the cesT allele is transcriptionally controlled by two differentially regulated promoter elements (Brouwers et al., 2012) . CesT homodimers have been shown to interact with at least 10 of the 21 annotated EPEC effectors (Tir, Map, EspF, EspH, EspG, EspZ, NleA, NleG, NleH1 and NleH2) , which suggests a central role for this class 1B multicargo chaperone in the EPEC pathogenic strategy . CesT-effector interactions are believed to be mediated by a modestly conserved 'chaperone binding domain' (CBD) located within the amino terminal region of many effectors (Thomas et al., 2007) . Some EPEC/EHEC effectors apparently do not interact with CesT (e.g., NleC, NleD and NleE), and as expected many of these effectors have been experimentally demonstrated to not require CesT for secretion or translocation into host cells during bacterial infection (Mills et al., 2008) .
CesT shares structural similarity with T3SC of other pathogens, however, it possesses a unique 25 amino acid carboxyl terminal region. As a family of proteins, T3SC are thought to interact with the cytoplasmic face of the membrane located T3SS apparatus (Galan et al., 2014; Portaliou et al., 2017) . CesT has been shown to interact with EscN, a hexameric ATPase that is required for T3SS function (Gauthier and Finlay, 2003; Thomas et al., 2005) . A genetic screen to assess CesT function identified many CesT C-terminal substitution variants that were defective for effector secretion (Ramu et al., 2013) . Specifically, some CesT variants only supported Tir secretion and not other effectors, thus implicating the C-terminal region of CesT in coordinating effector secretion. Interestingly, in EHEC O157:H7, CesT has been shown to be tyrosine phosphorylated within its Cterminal region on residues Y152 and Y153 (Hansen et al., 2013) and we have shown this for EPEC CesT as well (Runte and Thomas, unpublished results). Exactly how CesT coordinates multiple effector secretion and what role tyrosine phosphorylation plays in the process remains unknown.
In this study, we provide evidence for genetically separable functions linked to two strictly conserved tandem tyrosine phosphosites within CesT. We demonstrate a CesT mediated regulatory role during EPEC infection that impacts overall pathogenesis. The finding of functionally relevant tandem tyrosine phosphosites, each with differential roles in type 3 secretion associated events, is a novel paradigm in EPEC pathogenesis. associated with animal reservoirs (cow, pig, dog, rabbit, sheep) . Low frequency conservative substitutions occur across most of the CesT sequence, however, we noted amino acids Tyr152 and Tyr153 are without exception strictly conserved in all LEE-PAI pathogenic strains, including Citrobacter rodentium, an A/E mouse pathogen (Fig. 1A) . Notably, Tyr152 and Tyr153 of CesT have been observed to be phosphorylated in EHEC O157:H7 (Hansen et al., 2013) , and we have identified the same site-specific modifications for EPEC (Runte and Thomas, unpublished results) (Supporting Information Fig. S1 ). These findings suggest that this localized region could be involved in regulatory or secretory events. Monospecific antibodies raised against an EPEC CesT C-terminal peptide detected CesT proteins in EHEC O157:H7 and C. rodentium lysates, thus verifying native expression of the respective proteins (Fig. 1B) . The observation that two adjacent tyrosines are strictly maintained and are subject to post-translational modification within a structurally disordered region of CesT, strengthened our hypothesis that both Tyr152 and Tyr153 phosphosites are important for CesT function.
Efficient F-actin pedestal formation requires CesT Tyr152 or Tyr153
The Tir effector is an essential host colonization factor (Ritchie et al., 2003; Deng et al., 2004) . During infection of in vitro cultured human epithelial cells, CesT is required for efficient Tir translocation by EPEC (Thomas et al., 2007) . To investigate whether conserved CesT tyrosine phosphosites contribute to Tir translocation, we performed HeLa cell infection assays with EPEC strains expressing CesT with conservative tyrosine to phenylalanine substitutions. This approach allows for retention of CesT secondary structure, and abrogates any potential for phosphorylation (i.e., removal of critical hydroxyl group). We generated EPEC strains that express (i) CesT Y152F, (ii) CesT Y153F and (iii) CesT Y152F, Y153F (non-phosphorylatable at positions 152 and 153). Importantly, these strains maintain the normal chromosomal operon organization that is involved in dual transcriptional regulation of cesT mRNA expression (Brouwers et al., 2012) and were found to produce the respective CesT variants (tyrosine to phenylalanine) at levels equivalent to wild type CesT as determined by immunoblotting with anti-CesT antibodies ( Fig. 2A) . Therefore, CesT tyrosine phosphosites 152 and 153 are not essential for maintaining CesT steady state levels in EPEC. Moreover, and as expected, these strains were unchanged for secreted levels of T3SS translocator proteins EspA, EspB and EspD, along with EspC (type V secreted) ( Fig. 2A) , a process known to be CesTindependent (Abe et al., 1999; Thomas et al., 2005) .
The ability of the CesT tyrosine to phenylalanine substitution variants to support A/E lesion formation was assessed using an in vitro HeLa cell infection assay where EPEC clusters HeLa cell F-actin in a Tir-dependent manner, forming actin-rich 'pedestals'. We used fluorescence microscopy with a defined rule set to enumerate pedestals per HeLa cell for each infection condition (see experimental procedures). As expected, EPEC formed robust F-actin pedestals on HeLa cell infection whereas in sharp contrast a cesT null mutant was significantly deficient in the process (Fig. 2B ). These data confirm previous reports and demonstrate that efficient EPEC actin pedestal formation is CesT-dependent (Abe et al., 1999; Elliott et al., 1999; Thomas et al., 2007) . When EPEC expressing CesT Y152F or CesT Y153F was used to infect HeLa cells, F-actin pedestals were readily detected, resembling wild type EPEC. In contrast, when EPEC expressing Fig. 2 . In vitro secretion and infection assays to characterize EPEC or EPEC mutants with tyrosine to phenylalanine substitutions within CesT. A. Assessment of whole cell lysates and total secreted proteins derived from various EPEC strains. Whole cell lysates were probed with anti-CesT or anti-RNA polymerase antibodies. Total secreted proteins collected from the same cultures were stained with Coomassie G-250. The secreted protein profile of EPEC has been well characterized and the labeled proteins have been previously identified by mass spectrometry (Thomas et al., 2005 (Thomas et al., , 2007 . B. Mock treated (uninfected) or EPEC infected HeLa cells were stained with fluorescent phalloidin to detect F-actin (red). All bacterial strains contained a plasmid encoding green fluorescent protein. Note the appearance of robust F-actin condensation (actin pedestals) for specific bacterial strains. Representative images of each condition are shown. C. Quantification of EPEC strain intimate attachment using a defined binding index assay as described in the Methods section. Scale bar represent standard deviation from the mean. A paired t test was used to determine statistical significance; **p 5 0.0022, ***p 5 0.0001. non-phosphorylatable CesT Y152F, Y153F was used to infect HeLa cells, F-actin pedestal formation was significantly attenuated (p 5 0.002) (Fig. 2C) . We confirmed that each of the bacterial strains expressed their respective CesT variant by collecting infected HeLa lysates and immunoblotting for CesT (Supporting Information Fig. S2 ). We also considered the possibility that CesT tyrosine substitution variants (i) Y152F, (ii) Y153F and (iii) Y152F, Y153F may not bind Tir efficiently. Using an established in vitro effector binding assay, it was determined that the CesT tyrosine to phenylalanine variants bound Tir (and other effectors) relatively equal to native CesT (Supporting Information Fig. S3 ). Collectively, these data suggest that the CesT tyrosines (Y152 or Y153) contribute to the ability of EPEC to form F-actin pedestals on HeLa cells.
EPEC expressing site specific phospho-deficient CesT variants produce altered secreted levels of multiple effectors Given our findings implicating conserved CesT Cterminal tyrosines for Tir injection into host cells, we set out to investigate if the secretion and translocation of other EPEC effectors are dependent on CesT tyrosine 152 and 153. Five CesT-interacting effectors (EspF, NleA, NleH1, NleH2 and Tir) were selected to generate chromosomally encoded C-terminal beta-lactamase (TEM-1) translational fusions within EPEC, DcesT, and each of the tyrosine to phenylalanine substitution mutants. The rationale for selecting these effectors was because they are encoded from three separate prophage or pathogenicity islands (LEE, PP2, PP6) and would thus widely inform on a potential role for the specific CesT tyrosine residues. This experimental approach allowed for detection of (i) multiple effectors during in vitro secretion assays using high affinity commercial antibodies and (ii) quantitative real-time measurement of effector translocation during infection (i.e., EPEC mediated effector injection into HeLa cells).
Initially, we assessed if the encoded effector-TEM-1 fusions were secreted into culture supernatants. All wild type EPEC strains supported efficient secretion of each effector-TEM-1 fusion (Fig. 3A) . The secretion of the effector-TEM-1 fusions were CesT-dependent in all but one case (EspF, see discussion), as they were not detected in culture supernatants derived from cesT null mutants ( Fig. 3B-F) . For NleA-TEM-1, its secretion was abolished with substitution of the CesT Y152 phosphosite in two separate strains (Y152F; and Y152F, Y153F) (Fig. 3A) . Interestingly, in the case of cesT Y153F (where only the CesT Y152 phosphosite remains) NleA-TEM-1 secretion was significantly higher than wild type ( Fig. 3C ; p 5 0.036). This represented a unique situation among the studied effectors so we assessed total cell lysates from the relevant strains which revealed that NleA-TEM-1 was exclusively detected when CesT Y152 was intact (only for wild type EPEC and cesT Y153F) (Fig. 3G) . Moreover, whole cell lysate levels of NleA-TEM-1 were consistently higher for cesT Y153F than wild type EPEC, an observation that agreed with the secretion trends. Therefore, under these culture conditions, the data indicated that the CesT Y152 phosphosite was required for NleA expression, and that substitution of CesT Y153 to F153 increased the levels of NleA expression and its subsequent secretion.
Observed differences in Tir-TEM-1, NleH1-TEM-1 and NleH2-TEM-1 secretion in context of the CesT variants were less striking than for NleA-TEM-1. Nonetheless, secretion of Tir, NleH1 and NleH2 was always most efficient with CesT Y152 intact (Fig. 3A , D and E). Furthermore, all EPEC strains expressing non-phosphorylatable CesT Y152F, Y153F demonstrated lower secreted levels of these effector-TEM-1 fusions than EPEC with native CesT. In each case total cell lysate levels of the Tir, NleH1, NleH2 effector-TEM fusions were comparable (data not shown). The results indicate that CesT phosphosites Y152 or Y153 are not absolutely required for in vitro secretion of Tir, NleH1 and NleH2, however, the presence of the CesT Y152 phosphosite promotes more efficient secretion of these effectors. The effector-TEM-1 secretion results are suggestive of an important role for the CesT Y152 phosphosite in overall EPEC effector secretion.
One disadvantage of studying effector-b-lactamase fusion proteins is that they represent altered and unnatural secretion substrates, which could potentially have different secretion outcomes. To address this, we employed an EPEC DsepD strain that is known to hyper-secrete multiple natively expressed effector proteins into culture supernatants in a CesT-dependent manner (Supporting Information Fig. S4 ). We reasoned that this EPEC strain should exhibit specific tyrosine phosphosite dependent phenotypes associated with CesT (i.e., that agree with observations for strains expressing recombinant effector-TEM-1 fusions). We found that plasmid encoded CesT Y152F failed to restore total effector secretion, whereas CesT Y153F completely returned effector secretion. Therefore, data from two independent approaches suggest a critical role for the CesT Y152 phosphosite in total in vitro effector secretion for EPEC.
EPEC expressing site specific phospho-deficient CesT variants exhibit altered effector translocation kinetics during real-time in vitro infection conditions
The injection of EPEC effectors into host cells via the T3SS is a functionally relevant process leading to host cell subversion during infection. Therefore, we set out to investigate the role of the implicated CesT tyrosine phosphosites in supporting the injection of NleA-TEM-1, NleH-TEM-1, NleH2-TEM-1, EspF-TEM-1 and Tir-TEM-1 into HeLa cells during EPEC infection. An empirically determined multiplicity of infection of 200 was used for these assays, which lead to notable translocation efficiency differences between EPEC and DcesT strains for all studied effector-TEM-1 fusions (Supporting Information Fig. S5 ). For EPEC expressing Tir-TEM-1, translocation was detected 20-30 min postinfection reaching its maximal level at 60-70 min postinfection (Fig. 4A) . Here, Tir-TEM-1 translocation was found to be significantly different from a cesT null mutant that supported near baseline levels of Tir-TEM-1 translocation (p < 0.01) (Supporting Information Table S1 ). Analyses of specific EPEC CesT tyrosine to phenylalanine substitution variants revealed efficient Tir-TEM-1 translocation for bacteria expressing CesT Y152F or CesT Y153F that closely resembled EPEC with normal CesT. In contrast, EPEC expressing non-phosphorylatable CesT Y152F, Y153F consistently exhibited reduced levels and a slower rate of Tir-TEM-1 translocation (see curve slope in Fig. 4A ). The reduced levels did not reach statistical significance compared to EPEC expressing CesT, however, indicate a trend implicating CesT residues Y152 and Y153 in Tir translocation efficiency (see F-actin pedestal assay observations in Fig. 2 ). In assessing these data, it should be noted that enzymatic translocation and F-actin pedestal assays measure different biological processes. Specifically, Tir-TEM-1 injection into host cells is measured by the enzymatic activity of TEM-1 on a cell-loaded CCF2-AM substrate (Charpentier and Oswald, 2004; Mills et al., 2008) , whereas F-actin pedestals are the outcome of a multistep host driven signalling cascade initiated by efficient Tir injection and clustering.
Next, we assessed the role of CesT tyrosines on NleA-TEM-1 translocation into HeLa cells. EPEC expressing CesT exhibited augmented NleA-TEM-1 translocation 50 min postinfection deviating from the baseline levels observed for the cesT null strain (Fig. 4B) . Interestingly, EPEC expressing CesT Y153F (which has the Y152 phosphosite intact) resulted in an increased amount of translocated NleA-TEM-1 at 40 min postinfection, outperforming EPEC with native CesT. This reached statistical significance by 80 min postinfection (Supporting Information Table S2 ). In sharp contrast, EPEC expressing CesT Y152F or CesT Y152F, Y153F produced NleA-TEM-1 translocation levels that mimicked baseline DcesT levels. We verified that these strains were translocation competent (capable of injecting effectors) by assessing Tir translocation into host cells by immunoblotting the respective infection monolayer lysates. Indeed, EPEC expressing CesT Y152F or CesT Y152F, Y153F were shown to inject Tir into host cells (Fig. 4C ), indicating that a functional T3SS was expressed. Collectively, these data suggest that the CesT Y152 phosphosite was required for efficient NleA translocation and that increased translocation levels were achieved when CesT Y153 was substituted to phenylalanine.
EPEC strains expressing CesT Y152F, or CesT Y152F, Y153F were observed to support reduced translocation levels for NleH1-TEM-1, and NleH2-TEM-1 relative to EPEC with native CesT (Fig. 5A and B) . While translocation efficiency for these effectors was not reduced to DcesT levels (as noted for NleA-TEM-1), statistically significant differences were reached at 70-100 min postinfection in comparison to EPEC expressing CesT (summarized in detail, Supporting Information Table S2 ). For EPEC expressing CesT Y153F, NleH1-TEM-1 and NleH2-TEM-1 late translocation levels (80-100 min postinfection) were slightly elevated compared to EPEC expressing CesT although the difference did not reach statistical significance. In the EPEC strains expressing EspF-TEM-1, CesT Y153F supported the highest translocation level for all strains evaluated, even surpassing EPEC with native CesT (Fig. 5C , EspF represents an unusual effector in that it interacts with two different chaperones, CesF and CesT, see discussion). In summary, these data suggest that EPEC expressing CesT with the Y152 phosphosite intact supported high translocation efficiency for NleH1 and NleH2, although Y152 was not strictly required for translocation of these effectors. EspF translocation appeared to be modestly enhanced when CesT Y153 was substituted to phenylalanine.
C. rodentium requires the presence of CesT Tyr152 and Tyr153 for efficient mouse colonization
We set out to investigate whether specific C-terminal CesT tyrosines are important for bacterial intestinal colonization and disease in a natural mouse infection model for A/E pathogenesis. C. rodentium has been widely used by researchers to assess the role of its putative virulence factors in mice, including many aspects of its cognate T3SS and numerous effectors (Deng et al., 2003 (Deng et al., , 2004 Collins et al., 2014; Crepin et al., 2016 , Buschor et al., 2017 . Importantly C. rodentium cesT null mutants have been shown to be strongly attenuated for mouse intestinal colonization and disease (Deng et al., 2004) .
Given the important role for the CesT Y152 phosphosite for EPEC effector injection into host cells, we generated C. rodentium substitution mutants that express either CesT Y152F, CesT Y153F or CesT Y152F, Y153F. Next, 6 groups of healthy C57BL/6 mice (n 5 5) were infected by oral gavage with the following C. rodentium strains; (i) wild type, (ii) cesT Y152F, (iii) cesT Y153F, (iv) cesT Y152F, Y153F, (v) DcesT and (vi) DnleA. The last 2 groups were included to provide a comparison to previously published observations for highly attenuated C. rodentium mouse infections (Deng et al., 2004; Mundy et al., 2004) . A seventh group of mice was kept uninfected and monitored throughout the course of the 9 day experiment. Fecal shedding of C. rodentium was followed for each group of mice at day 3, 5, 7 and 9. Mice were then sacrificed at Day 9 to assess C. rodentium colon counts. Importantly, no C. rodentium were detected at any time in the uninfected mice (data not shown).
Three days postinfection, most mice from all treatment groups except DcesT shed C. rodentium at levels clustering at 10 5 cfu/g feces although considerable variability in shedding was observed for individual mice in each group (Fig. 6A ). For 4/5 DcesT infected mice, C. rodentium was not detected in fecal samples, with the remaining mouse shedding 10 5 cfu/g feces. Table S2 .
Notably, one and two mice from wild type and cesT Y153F respectively shed at 10 7 cfu/g feces. At day 5, average C. rodentium counts in feces were markedly different among groups with wild type and cesT Y153F having the highest average values near 10 8 cfu/g feces (Fig. 6A) . The average count for cesT Y152F was lower at 10 7 cfu/g feces, followed by an even lower average count of 10 5 cfu/g stool for cesT Y152F, Y153F. At or near Day 7, C57BL/6 mice are known to exhibit maximal C. rodentium fecal shedding (Raczynski et al., 2012) . As expected, the average C. rodentium fecal shedding count for wild type was high at 10 8 cfu/g stool (Fig. 6A) . Similar average values for cesT Y152F, cesT Y153F and cesT Y152F, Y153F were also detected. In contrast, and as expected, DnleA and DcesT strains were detected at much lower averages of 3.0 3 10 6 and 3.0 3 10 4 cfu/g feces respectively. At day 9, fecal C. rodentium average counts for wild type, cesT Y152F, and cesT Y153F remained high at 10 8 cfu/g stool (Fig. 6A) . Critically, the fecal shedding average count for cesT Y152F, Y153F sharply declined to 2.8 3 10 6 , close to the average detected for DnleA.
Lastly, DcesT exhibited the lowest average fecal count at 4.8 3 10 4 .
Taken together, the data indicate an early intestinal colonization defect for C. rodentium cesT Y152F and Fig. 6 . Shedding of C. rodentium strains determined from fecal samples of infected C57BL/6 mice (n 5 5 per group). Bacterial enumeration from feces collected at (A) day 3, day 5, day 7 and day 9 are represented with lines to indicate the mean 1 SD. B. The dynamics of shedding is presented as the mean for each experimental group at each time point. C. Bacterial enumeration from excised colon tissue at day 9 postinfection. Statistically significant cfu/g differences were determined by multiple unpaired t tests where indicated by asterisks (*, P < 0.05).
cesT Y152F, Y153F relative to wild type C. rodentium, a trend that was evident up to day 5 postinfection. As the infection progressed, cesT Y152F, Y153F were shed at high numbers but rapidly declined, differing from wild type, cesT Y152F, and cesT Y153F bacteria which maintained high fecal shedding counts. The fecal shedding data (summarized in Fig. 6B over 9 days) suggest that CesT Y152 and Y153 jointly contributed to efficient colonization of the mouse intestine although the presence of a single tyrosine at Y153 (i.e., strain cesT Y152F) was sufficient to support delayed colonization.
Next, on Day 9 the mice were sacrificed and colon samples were collected to assess tissue and mucosalassociated C. rodentium counts from each group of mice. As shown in Fig. 6C , mice infected with wild type, cesT Y152F, and cesT Y153F each had high average colon counts, ranging from 1.5 3 10 7 (wild type) to 1.4
3 10 8 cfu/g tissue. Consistent with reduced fecal counts, mice infected with cesT Y152F, Y153F exhibited a lower average colon burden at 2.4 3 10 6 . As expected, mice infected with DnleA or DcesT were highly attenuated and had a very low colon tissue burden ranging from 10 4 to 10 6 with only 1 mouse from each group producing counts at day 9.
Discussion
In this study, we provide evidence suggesting that strictly conserved tandem tyrosine phosphosites within CesT function to regulate type 3 effector secretion within A/E pathogens. Using complementary genetic, biochemical and infection biology approaches, we implicate CesT Y152 and Y153 in the development of enteric disease. Strikingly, bacteria expressing structurally conservative non-phosphorylatable phenylalanine substitutions in place of specific tyrosines within CesT, were significantly deficient in effector translocation and strongly attenuated for in vivo colonization. Another new observation for the T3SS chaperone CesT is the dependence of a specific tyrosine residue in the expression of an effector protein, in this case demonstrated for EPEC NleA. CesT Y152 appears to be correlated with maximal effector translocation efficiency, a trend observed for multiple effectors found in different EPEC prophage and pathogenicity islands. The only exception we observed was for EspF translocation. EspF interacts with its own chaperone CesF (Elliott et al., 2002) , yet can also interact with CesT (Thomas et al., 2005 (Thomas et al., , 2007 . Curiously, we observed maximal levels of EspF translocation in context of CesT Y153F (normal for the Y152 phosphosite). EspF thus represents an example of an effector with a very complex T3SS trafficking paradigm.
Our data implicates CesT Y152 as a critical node for efficient EPEC effector translocation. Evidence for this interpretation comes from multiple experiments. First, EPEC expressing CesT Y152F was shown to support significantly reduced levels of effector translocation for NleA, NleH1 and NleH2. Second, CesT Y152 was strictly required for NleA expression, which is a unique and novel observation among the effectors we evaluated. Third, phenylalanine substitution at the adjacent CesT 153 residue generated enhanced translocation levels of many effectors, exceeding levels supported by wild type CesT. Critically, these observations raise the paradoxical question as to why A/E pathogens have not undergone selective evolutionary pressure to alter Tyr153 to Phe153 via mutation (a single nucleotide change). The lack of such an occurrence, given its apparent effector translocation benefits, strongly suggests that A/E pathogens maintain a complex regulatory interplay at adjacent tyrosine phosphosites (Y152 and Y153), a feature that we find to be important for effector secretion.
It has been proposed that CesAB (EspA chaperone) and CesT interact with an inner membrane T3SS assembly in an EscV-dependent manner (Portaliou et al., 2017) . Furthermore, a C-terminal tail of CesAB was critical for the EscV interaction. It is tempting to speculate the same is true for CesT, especially in context of our previous observations relating to the C-terminal region of CesT (Ramu et al., 2013) . Interestingly, FlgN, a Salmonella type III export flagellar chaperone, requires a highly conserved C-terminal Tyr122 residue to interact with FlhA (its EscV homologue) to support flagellar assembly (Minamino et al., 2012) . Moreover, another multicargo type III secretion chaperone, HpaB of Xanthomonas, was shown to interact with HrcV (EscV family) (Alegria et al., 2004) . Therefore, it appears that chaperone 'docking' interactions with FlhA/EscV homologues is a recurring theme in type III secretion, and perhaps site specific and contextual tyrosines are involved.
CesT is known to be required for efficient C. rodentium mouse intestinal colonization (Deng et al., 2004) . We have reproduced those results and now extend the findings by revealing C-terminal tandem tyrosine residues within CesT are important for early intestinal colonization. We did observe that C. rodentium (CesT F152, F153) did replicate within mice, but was cleared from the mouse colon more rapidly than wild type C. rodentium. Recently, it has been demonstrated that the establishment phase of C. rodentium pathogenesis in vivo is restricted to a very short window of opportunity (18 hours) that determines intestinal intimate attachment and disease severity (Buschor et al., 2017) . Indeed, our data directly agree with those findings in that bacteria expressing CesT F152, F153 were attenuated for F-actin pedestal formation (EPEC) and mouse intestinal infection (C. rodentium). Therefore, CesT acts as a critical interaction node within the bacterial cell that supports A/E pathogenesis.
Tyrosine phosphorylation often creates high affinity binding sites for other proteins. It has been demonstrated that both EPEC and EHEC O157:H7 monophosphorylate CesT on Y152 or Y153 during in vitro growth conditions (Supporting Information Fig. S1 ) (Hansen et al., 2013) . Substitution of CesT Y152 to F152 would abrogate localized phosphorylation, hence the absence of site-specific phosphorylation might explain our observations. The same would be true for CesT F153. In the case of CesT F152, F153, absolutely no localized phosphorylation could occur. Strikingly, our experiments reveal that bacteria expressing non-phosphorylatable CesT F152, F153 exhibited the lowest effector translocation efficiencies (in vitro) and attenuated mouse intestinal colonization (in vivo). Alternatively, the hydroxyl group on tyrosine 152 and 153 (and absent from the structurally similar phenylalanine) might serve a very localized role within CesT such as hydrogen bonding with another protein. Critically, the current data cannot distinguish the aforementioned possibilities. The discovery of a bacterial kinase responsible for phosphorylating CesT, along with its inhibition, will be required to address these very challenging questions.
The prophage encoded effector NleA is a critical virulence determinant of A/E pathogens (Kim et al., 2007; Yen et al., 2015) (Fig. 6) . EPEC NleA expression is regulated by a post-transcriptional process where nleA mRNA is bound by the RNA binding protein CsrA to prevent its translation until T3SS-mediated host cell contact (Katsowich et al., 2017) . CesT was further shown to relieve translation inhibition by interacting and displacing CsrA from the nleA mRNA transcript. Here, we provide evidence that only EPEC expressing CesT with Y152 supports NleA expression. Surprisingly, we observed that CesT Y153F (with the Y152 phosphosite intact) significantly outperformed wild type CesT for NleA protein expression levels and translocation kinetics. This raises the intriguing possibility that Y152 of CesT might serve as a critical site for its interaction with CsrA, and thus promote NleA translation.
T3SS class 1 chaperones have been historically considered a group of structurally conserved proteins that function to maintain effector proteins in a secretion competent state within the bacterial cell (Wattiau et al., 1994; Stebbins and Galan, 2001; Page and Parsot, 2002) . Evidence now indicates that T3SS chaperones also function to recruit effectors either to a 'sorting platform' or the cytoplasmic face of the inner membrane associated T3SS apparatus resulting in effector secretion (Lara-Tejero et al., 2011; Portaliou et al., 2017) . For the multicargo chaperone CesT, effector binding and recruiting functions have been demonstrated to be functionally independent (Thomas et al., 2005; Ramu et al., 2013) , and here we implicate strictly conserved CesT tyrosine phosphosites in differential regulation of effector secretion. We hypothesize that CesT Y152, and perhaps its phosphorylation, serves as a high affinity binding site for a specific protein component of the T3SS.
Experimental procedures

Bacterial strains and growth media
Bacterial strains generated and used in this study are listed in Supporting Information 
Isolation of genomic and plasmid DNA
Genomic DNA was isolated from bacterial strains using the Purogene genomic DNA isolation kit (Gentra systems). Plasmids were isolated from bacterial strains using the QIAprep spin miniprep kit (Qiagen).
Construction of cesT substitution mutants in EPEC E2348/69 and Citrobacter rodentium EPEC and C. rodentium strains that express CesT tyrosine to phenylalanine variants were generated by mutating the chromosomal cesT allele using allelic exchange (Ramu et al., 2013) . Briefly, primers NT379 and NT380 were used in a PCR with EPEC genomic DNA to generate a 857 bp DNA product that was directionally cloned into pBluescript SacI and EcoRV sites, to generate pEPcesT. This plasmid was digested with NdeI and KpnI to serve as the vector backbone for synthesized cesT sequence gene blocks (Integrated DNA Technologies) that code for specific tyrosine to phenylalanine substitutions within CesT (Supporting Information Table S4 ). The gene blocks were directionally cloned as NdeI/KpnI fragments. The respective recombinant clones which encompass the tir-cesT-eae locus (each containing specific cesT mutations) were then subcloned as SacI/KpnI DNA fragments into suicide plasmid pRE112 using DH5akpir as a cloning host. A similar approach was used for Citrobacter using primers NT381 and NT382 for PCR with Citrobacter DNA to generate pCRcesT, followed by ligation cloning to gene blocks coding for specific Citrobacter cesT alleles in pRE112. All cesT mutations within their respective suicide plasmid constructs were verified by DNA sequencing. Suicide plasmid constructs were mobilized into recipient strains via triparental mating with recipient single crossover merodiploid clones (EPEC or Citrobacter) being selected with solid growth media containing streptomycin and chloramphenicol (for EPEC) or ampicillin and chloramphenicol (for Citrobacter). After streak purification of merodiploid clones on selective antibiotic media, sucrose selection was performed to isolate mutants as previously described (Ramu et al., 2013) . Bacterial isolates that exhibited growth on sucrose but not chloramphenicol were then streak purified. For each targeted mutation, several isolates were subjected to PCR analysis for the cesT allele, followed by DNA sequencing of the PCR amplicons. This approach yielded several cesT mutants.
Protein electrophoresis and immunoblotting
All protein samples were separated by SDS-PAGE as previously described (Laemmli, 1970) . For routine protein gels, separated polypeptides were visualized by Coomassie G-250 staining. Alternatively, for mass spectrometry analyses, colloidal blue or silver staining was employed. Prestained All-blue Protein Markers (Bio-Rad) were routinely used as molecular weight standards. For immunoblotting, separated polypeptides were transferred to Immobilon-P membrane (Millipore), blocked with skim milk (5% [w/v] in Tris buffered saline 1 Tween20 [TBS-T]), and then incubated with specific antibodies at working concentrations; anti-FLAG, 1:10 000 (Sigma); anti-RNApol, 1:2000 (Santa Cruz Biotech); anti-calreticulin,1:2000 (Calbiochem); anti-TEM-1, 1:5000 (Quantum Biosciences); anti-Tir, 1:1000 (Thomas et al., 2007) ; goat anti-mouse IgG conjugated to horse radish peroxidise (HRP), 1:5000 (Rockland immunochemicals); goat anti-rabbit IgG conjugated to HRP, 1:5000 (Rockland immunochemicals). High affinity anti-CesT monospecific antibodies were raised against a synthetic peptide (LENEHMKIEEISSSDNK) corresponding to the Cterminal region of CesT and were affinity purified against the peptide by the supplier (Pacific Immunology) and used in immunoblots at a 1:10 000 dilution (Ramu et al., 2013) . Immunoblots were developed using Clarity chemiluminescence reagent (Bio-Rad) and data captured on a VersaDoc 5000MP (Bio-Rad). Densitometry analyses of chemiluminescent signals was performed using ImageLab software (Bio-Rad). All immunoblotting experiments were performed three independent times, with a representative image shown.
HeLa cell infection and F-actin pedestal assays
HeLa cells (American Type Culture Collection) were seeded (5 3 10 5 ) into 60 mm culture dishes and grown overnight in DMEM supplemented with 10% fetal bovine serum (Invitrogen). Monolayers were then infected with EPEC or EPEC mutant strains for 3.5 h. The infected HeLa cell monolayers were then mechanically fractionated as previously described (Gauthier et al., 2000) . The resulting samples were prepared for SDS-PAGE and immunoblotting. For F-actin pedestal assays, HeLa cells on glass coverslips were infected with EPEC strains for 3.5 h (or 9 h with Citrobacter strains). The samples were washed three times with PBS to remove weakly or non-adherent bacteria and then fixed with paraformaldehyde. The samples were then prepared for fluorescence microscopy as previously described (Thomas et al., 2007) . Quantification of intimate bacterial attachment (binding index) was conducted as previously described (Thomassin et al., 2011) . Briefly, the percentage of HeLa cells harboring at least five GFP-positive bacteria (identified by GFP fluorescence) that were associated with F-actin condensation were quantified. Three independent experiments were performed, with at least 50 HeLa cells examined per sample.
Generation of chromosomally encoded effector-b-lactamase fusions
The coding regions of CesT-interacting T3SS effectors NleA, NleH1 and NleH2 were amplified by PCR and cloned into pCX341 to generate C-terminal translational fusions to TEM-1 b-lactamase (encoded by the blaM gene). This cloning step was carried out in DH5akpir E. coli. The effectorblaM fusion constructs in pCX341-based plasmids were excised with KpnI and XbaI digests, and subcloned into the pCX391 suicide plasmid digested with KpnI and XbaI. These constructs were added to competent DH5akpir cells and transformants selected on LB tetracycline (10 lg ml 21 ) plates. The pCX442 (Tir-TEM-1) and pCX446 (EspF-TEM-1) suicide plasmids derived from pCX391 were previously received from Ilan Rosenshine. These plasmids were transformed into DH5akpir to finalize a total of five donor strains to be used in a conjugation experiment. Each donor contained a single pCX391-based effector-blaM fusion that was to be targeted for chromosomal integration within five different EPEC recipient strains: wild type, DcesT, cesT(Y152F), cesT(Y153F) and cesT(Y152F,Y153F). Single crossover integration of the plasmid via homologous recombination conferred resistance to tetracycline for the EPEC recipients. Streptomycin (50 lg ml
21
) was included in the selection media to prevent growth of DH5akpir donors. Suicide plasmid-encoded effector-blaM constructs were verified by sequencing prior to conjugation.
Real-time effector translocation assays
On day 1, HeLa cells were seeded in 96-well plates (black with clear bottom, ThermoFisher Scientific) at a density of 2 3 10 4 cells/well in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS). In parallel, bacterial strains encoding chromosomal effector-blaM fusions were grown overnight in LB at 378C, shaking at 200 rpm. On day 2, bacterial cultures were diluted 1/200 into DMEM and grown statically in conditions known to stimulate T3SS expression (378C, 5% CO 2 for 4 h to OD 600 nm of 0.2-0.35) to create a 'pre-activated' culture. At the 3-h mark of the culture preactivation, HeLa cells were washed twice with DMEM 110% FBS 12.5 mM probenecid (herein referred to as DFP media), and treated with 20 ll of 6X CCF2-AM substrate loading solution dissolved in 100 ll DFP media. The cells were incubated for 40 min at room temperature in the dark, CesT coordinates effector secretion in EPEC 547 then washed an additional 33 with 100 ll DFP to titer out extracellular CCF2-AM substrate from the growth media. OD 600 nm measurements were recorded for each bacterial culture at the 4 h mark of preactivation to normalize infection inoculum to MOI 50, 100 or 200. Immediately on bacterial inoculation, the plates were placed in a plate reader (Victor X5; PerkinElmer) set to 378C, which was where the infection took place. Infected cells were excited at 405 nm, and emission was recorded at 460 nm and 535 nm at 10 min intervals over the course of infection. Experimental data were collected with PerkinElmer 2030 software and adjusted for background blue and green fluorescence using the following formula in Microsoft excel (V C 2015): 
Mouse infections with Citrobacter rodentium
Female C57BL/6 mice (Charles River Laboratories) were acclimatized for 7 days in our specific pathogen-free facility. The mice were then randomized into seven groups (n 5 5 per group), for six treatments and 1 mock infection. Bacterial inocula for the respective mouse infections were prepared by growing 50 ml cultures in LB broth (16 h, 378C, 200 rpm), started from a freshly grown single colony. The overnight cultures were pelleted by centrifugation and then resuspended in 5 ml of sterile PBS followed by normalization for cell number. The cultures were then promptly used to infect mice by oral gavage (200 ll per mouse). The remaining culture was used to confirm the respective inocula by plating onto LB agar. Fecal pellets were collected at Day 3, 5, 7 and 9 for each treatment group and plated on Mackonkey agar to enumerate C. rodentium. After 9 days, mice were sacrificed to collect colon samples. The colons were weighed, flushed with ice cold PBS to remove fibrous material. A distal 2 cm sample was weighed, homogenized in PBS, followed by serial dilution and plating onto Mackonkey agar. Citrobacter colonies appeared as white with pink centres after 24 h of growth at 378C.
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